- Home
- PWOD vs CRVS Comparison
PWOD vs CRVS Comparison
Compare PWOD & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWOD
- CRVS
- Stock Information
- Founded
- PWOD 1934
- CRVS 2014
- Country
- PWOD United States
- CRVS United States
- Employees
- PWOD N/A
- CRVS N/A
- Industry
- PWOD Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- PWOD Finance
- CRVS Health Care
- Exchange
- PWOD Nasdaq
- CRVS Nasdaq
- Market Cap
- PWOD 173.1M
- CRVS 161.4M
- IPO Year
- PWOD N/A
- CRVS 2016
- Fundamental
- Price
- PWOD $22.24
- CRVS $5.83
- Analyst Decision
- PWOD
- CRVS Buy
- Analyst Count
- PWOD 0
- CRVS 4
- Target Price
- PWOD N/A
- CRVS $10.83
- AVG Volume (30 Days)
- PWOD 12.6K
- CRVS 468.1K
- Earning Date
- PWOD 10-23-2024
- CRVS 11-05-2024
- Dividend Yield
- PWOD 5.86%
- CRVS N/A
- EPS Growth
- PWOD N/A
- CRVS N/A
- EPS
- PWOD 2.31
- CRVS N/A
- Revenue
- PWOD $64,822,000.00
- CRVS N/A
- Revenue This Year
- PWOD N/A
- CRVS N/A
- Revenue Next Year
- PWOD N/A
- CRVS N/A
- P/E Ratio
- PWOD $9.45
- CRVS N/A
- Revenue Growth
- PWOD N/A
- CRVS N/A
- 52 Week Low
- PWOD $17.01
- CRVS $1.05
- 52 Week High
- PWOD $24.10
- CRVS $6.15
- Technical
- Relative Strength Index (RSI)
- PWOD 51.10
- CRVS 81.01
- Support Level
- PWOD $20.18
- CRVS $3.90
- Resistance Level
- PWOD $21.73
- CRVS $6.15
- Average True Range (ATR)
- PWOD 0.76
- CRVS 0.40
- MACD
- PWOD -0.04
- CRVS 0.14
- Stochastic Oscillator
- PWOD 50.85
- CRVS 95.33
About PWOD Penns Woods Bancorp Inc.
Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).